Mercury Bio, Inc.
Advanced bio-molecular drug delivery systems for therapeutics
- Sector
- Biotech
- Headquarters
- SANTA FE, NM
- Founded
- 2020
- Latest Form D
- $2.4M, Oct 2025
- Total capital
- $3.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.9M
- 5 Form D · last Oct 2025
- 12 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 27 pending · first 2024
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$2.4M
- Private capital raisedForm D · SEC · 4th filing$3K
- Private capital raisedForm D · SEC · 3rd filing$150K
- Private capital raisedForm D · SEC · 2nd filing$1.2M
- Private capital raisedForm D · SEC · 1st filing$200K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alex KoglinDirectorNamed in SEC Form D filings
- Bruce McCormickExecutive Officer, DirectorNamed in SEC Form D filings
- Dana BarnardDirectorNamed in SEC Form D filings
- John TomesDirectorNamed in SEC Form D filings
- Kevin McDonaldDirectorNamed in SEC Form D filings
- Mike RiceDirectorNamed in SEC Form D filings
Show all 10 people
- Paul LaurExecutive Officer, DirectorNamed in SEC Form D filings
- Steve BuelowDirectorNamed in SEC Form D filings
- Steve KiziukDirectorNamed in SEC Form D filings
- Tuck StibichDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 28- PendingMethods For Actively Loading Therapeutic Nucleic Acid Molecules Into Modified Extracellular Vesicles For The Targeted Delivery To CellsUSPTOApplication 19138527
- PendingMethods For Actively Loading Therapeutic Molecules Into Modified Extracellular Vesicles For Targeted Delivery To CellsUSPTOApplication 19119000
- PendingTargeted Extracellular Vesicles For Delivery Of TherapeuticsUSPTOApplication 18949090
Show all 28 patent records
- Methods For Actively Loading Therapeutic Nucleic Acid Molecules Into Modified Extracellular Vesicles For The Targeted Delivery To CellsJul 16, 2026 · Application 19138527Pending
- Methods For Actively Loading Therapeutic Molecules Into Modified Extracellular Vesicles For Targeted Delivery To CellsJun 18, 2026 · Application 19119000Pending
- Targeted Extracellular Vesicles For Delivery Of TherapeuticsApr 3, 2025 · Application 18949090Pending
- DIRECT PRODUCTION OF SIRNAS IN SACCHAROMYCES BOULARDII AND PACKAGING IN EXTRACELLULAR VESICLES (EVs) FOR TARGETED GENE SILENCINGFeb 13, 2025 · Application 18895210Pending
- Targeted Extracellular Vesicles For Delivery Of TherapeuticsDec 31, 2024 · US 12,180,481Granted
- Production And Delivery Of Therapeutic Nucleic Acids Packaged In Yeast Extracellular Vesicles Embedded In Biocompatible Implant MatricesApplication PCTUS2024038743Pending
- Rna Sorting Motifs For The Packaging Of Recombinant Rnas Into Yeast Extracellular VesiclesApplication PCTUS2024034173Pending
- Targeted Delivery Of CAS13D And Associated Guide Shrna To Silence Targeted Rnas Via Yeast Extracellular VesiclesApplication 63657964Pending
- Light-activated Loading Of Therapeutic Molecules Into Modified Extracellular Vesicles For Targeted Delivery To CellsApplication PCTUS2024023300Pending
- Optimization Of Yeast Mrna Structure And Sequence For Expression In Human CellsApplication 63573676Pending
- Methods For Actively Loading Therapeutic Nucleic Acid Molecules Into Modified Extracellular Vesicles For The Targeted Delivery To CellsApplication PCTUS2023083644Pending
- Chimeric Yeast Extracellular Vesicles For The Enhanced Delivery Of Therapeutic Molecules To CellsApplication 63547859Pending
- Methods For Actively Loading Therapeutic Molecules Into Modified Extracellular Vesicles For Targeted Delivery To CellsApplication PCTUS2023076329Pending
- Protein Sorting Motifs For The Packaging Of Therapeutic Proteins Into Yeast Extracellular Vesicles For Targeted Delivery To Cells And BloodApplication 63536478Pending
- Production And Delivery Of Therapeutic Nucleic Acids Packaged In Yeast Extracellular Vesicles Embedded In Biocompatible Implant MatricesApplication 63528123Pending
- Rna Sorting Motifs For The Packaging Of Recombinant Rnas Into Yeast Extracellular VesiclesApplication 63521078Pending
- Direct Production Of Sirnas In Saccharomyces Boulardii And Packaging In Extracellular Vesicles (evs) For Targeted Gene SilencingApplication PCTUS2023064756Pending
- Production And Delivery Of Therapeutic Nucleic Acids Packaged In Yeast Extracellular Vesicles Embedded In Biocompatible Implant MatricesApplication 19504298Pending
- Protein Sorting Motifs For The Packaging Of Therapeutic Proteins Into Yeast Extracellular Vesicles For Targeted Delivery To Cells And BloodApplication 19516401Pending
- Chimeric Yeast Extracellular Vesicles For The Enhanced Delivery Of Therapeutic Molecules To CellsApplication 19524852Pending
- Rna Sorting Motifs For The Packaging Of Recombinant Rnas Into Yeast Extracellular VesiclesApplication 19493508Pending
- Enhanced Tissue Regeneration Mediated By Yeast Extracellular Vesicle Delivery Of Therapeutic RnasApplication PCTUS2026017778Pending
- Enhanced Tissue Regeneration Mediated By Yeast Extracellular Vesicle Delivery Of Therapeutic RnasApplication 63768705Pending
- Light-activated Loading Of Therapeutic Molecules Into Modified Extracellular Vesicles For Targeted Delivery To CellsApplication 19524703Pending
- Targeted Delivery Of CAS13D And Associated Guide Shrna To Silence Targeted Rnas Via Yeast Extracellular VesiclesApplication PCTUS2025032564Pending
- Optimization Of Yeast Mrna Structure And Sequence For Expression In Human CellsApplication PCTUS2025022835Pending
- Chimeric Yeast Extracellular Vesicles For The Enhanced Delivery Of Therapeutic Molecules To CellsApplication PCTUS2024055232Pending
- Protein Sorting Motifs For The Packaging Oftherapeutic Proteins Into Yeast Extracellular Vesicles For Targeted Delivery To Cells And BloodApplication PCTUS2024045087Pending
Related companies, and why
- Resilient Biotics, Inc.Similar federal contract value in Biotech · null in contracts
- Model Medicines, Inc.Similar federal contract value in Biotech · null in contracts
- Vetmab Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Accipiter Biosciences Inc.Similar federal contract value in Biotech · null in contracts
- LAVO LIFE SCIENCES INCSimilar federal contract value in Biotech · null in contracts
- Violet TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .